A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry

A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry

Primary central nervous system lymphomas (PCNSL) account for approximately 2% to 3% of all primary brain tumors. Until now, neuropathological tumor tissue analysis, most frequently gained by stereotactic biopsy, is still the diagnostic gold standard. Here, we rigorously analyzed two independent pati...

Full description

Bibliographic Details
Main Authors: Daniel M. Waldera-Lupa, Gereon Poschmann, Nina Kirchgaessler, Omid Etemad-Parishanzadeh, Falk Baberg, Mareike Brocksieper, Sabine Seidel, Thomas Kowalski, Anna Brunn, Aiden Haghikia, Ralf Gold, Anja Stefanski, Martina Deckert, Uwe Schlegel, Kai Stühler
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
primary central nervous system lymphomas
secondary central nervous system lymphomas
multiple sclerosis
glioma
cerebrospinal fluid
biomarker
Online Access:https://www.mdpi.com/2072-6694/12/7/1732

Similar Items

Similar Items